NCT04081285View on ClinicalTrials.gov

Epigenetic Biomarkers for Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Alzheimer Disease
Trial Locations (1)

Unknown

The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Hong Kong University of Science and Technology

OTHER

lead

Chinese University of Hong Kong

OTHER

NCT04081285 - Epigenetic Biomarkers for Alzheimer's Disease | Biotech Hunter | Biotech Hunter